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ventricular septal defect on the beating heartBarry A. Love, MD,a Brian Whang, MD,b and Farzan Filsoufi, MD,b New York, NYWe report 2 cases of post-myocardial infarction ventricular
septal defect (PMI-VSD) closed successfully with Amplat-
zer septal occluders (AGAMedical Corp, Plymouth, Minn)
using a direct perventricular approach via median sternot-
omy. The procedures were performed on the beating heart
without cardiopulmonary bypass.CLINICAL SUMMARY
We describe 2 sexagenarian men hospitalized with acute
myocardial infarction and cardiogenic shock. In each,
cardiac catheterization revealed proximal occlusion of the
left anterior descending artery, and ventriculogram demon-
strated a large PMI-VSD. Step-up in pulmonary artery
saturation indicated pulmonary-to-systemic flow ratio of
3:1 and greater than 4:1 in each patient. Both received an
intra-aortic balloon pump and were referred for emergency
PMI-VSD closure.
Intraoperative transesophageal echocardiography in both
patients confirmed a large mid-muscular PMI-VSD (patient
1, 25 mm; patient 2, 28 mm) extending to the apex with left-
to-right shunt (Figure 1, A, B). A median sternotomy was
performed. Digital compression of the right ventricular
(RV) free wall identified the site on the RV directly opposite
the central portion of the PMI-VSD (Figure 1, C). In both
patients, this was approximately 4 cm basal to the cardiac
apex. A purse-string was placed, and an 18 g needle wasinserted through the purse-string, into the central portion
of the VSD, and into the LV cavity. A 0.038-inch–30-cm
J-wire was inserted into the LV. A 12F 13-cm Cook sheath
was advanced over the guidewire. In each patient,
a 34-mm Amplatzer septal occluder was then deployed.
The distal discwas delivered in the LV cavity and pulled flush
with the LV septum.With traction on the delivery system and
countertraction on the RV free wall, the proximal disc was
deployed on the exterior surface of the RV (Figure 2, A–
C). A 34-mm device was chosen so the left disc (50 mm)
would cover the defect and the adjacent infarcted muscle,
and extend to what appeared to be viable myocardium.
In the first patient, transesophageal echocardiography
showed closure of the VSD with minimal residual flow
(Figure 2, D). On postoperative day (POD) 1, he was extu-
bated and the intra-aortic balloon pump was removed. Echo-
cardiogram on POD 5 showed a tiny residual VSD, an LV
ejection fraction of 35%, and normal RV. The patient was
discharged on POD 5. He remained well for 3 weeks but re-
turned in acute low-output cardiac failure. Echocardiogram
showed minimal residual shunting but severely depressed
biventricular function. Despite inotropic support, progres-
sive acidosis developed and the patient died within 24 hours.
The second patient underwent off-pump left anterior de-
scending artery revascularization in the same setting, and he
was extubated on POD 1. Follow-up catheterization on
POD 10 showed a small residual VSD that was successfully
closed with a transcatheter Amplatzer muscular VSD oc-
cluder. The patient was discharged, and repeat catheteriza-
tion 5 months later showed minimal residual left-to-right
flow and a shunt fraction of less than 1.2:1. At 13 months
postoperatively, the patient is in New York Heart Associa-
tion class I–II.DISCUSSION
VSD complicates 0.2% of cases of acute myocardial
infarction.1 Most of these patients present with rapidery c July 2011
FIGURE 1. A, Intraoperative transesophageal echocardiography showing a 2.5-cm PMI-VSD extending from the mid-septum to the apex. B, Color Dopp-
ler shows left-to-right shunt. C, Manual digital compression of the RV free wall against the septum shows occlusion of the VSD. Arrow indicates the op-
erator’s index finger.
Brief Technique Reportshemodynamic deterioration and cardiogenic shock requir-
ing emergency surgical intervention. Acute surgical repair
of PMI-VSD carries an operative mortality as high as
40%.2 In the presence of such high risk, alternative thera-
peutic approaches such as transcatheter PMI-VSD closure
have been attempted.3 There continues to be a high morbid-
ity and mortality with this approach. The major problem in
the acute setting is the evolving nature of the PMI-VSD thatFIGURE 2. A, In the same patient, delivery of a 34-mm Amplatzer (AGA M
deployment of the proximal disc (44-mm diameter) on the exterior surface o
purse-string was tied and a patch of bovine pericardium was secured between th
geal echocardiography shows the device in place against the LV septum (distal di
D, Color Doppler shows no significant residual VSD flow.
The Journal of Thoracic and Cais associated with the persistence of hemodynamically sig-
nificant residual shunts in a great number of patients.4 To
minimize residual shunt, a device 50% larger than the ex-
tent of the VSD has been recommended.4 For large VSDs,
however, the large delivery system necessary makes trans-
catheter delivery difficult, if not impossible.
For our 2 patients, we applied a hybrid technique origi-
nally described to treat congenital muscular VSDs in smalledical Corp, Plymouth, Minn) septal occluder device through the RV and
f the RV. B, After the device was detached from the delivery cable, the
e occluder and the RV free wall to prevent device erosion. C, Transesopha-
sc diameter, 50 mm) and the proximal disc on the exterior surface of the RV.
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Brief Technique Reportschildren.5 An open surgical technique with a direct perven-
tricular approach greatly facilitated the delivery of a large
device. Plicating the apical RV free wall to the VSD margin
by deploying the proximal disc on the exterior surface of the
RV served to minimize the degree of residual shunting from
such a large defect. Furthermore, avoidance of conventional
surgical techniques eliminated the risks associated with car-
diopulmonary bypass, myocardial ischemia, and the im-
plantation of a patch into extremely fragile tissue. Finally,
the procedure was performed in a short period of time
(<10 minutes) without significant cardiac manipulation
and with a safe bail-out.
CONCLUSIONS
To our knowledge, this is the first report of a hybrid
approach in the treatment of PMI-VSD. The procedure
seems safe and effective, and may play a major role in the
management of this very high-risk group of patients. Al-
though perventricular delivery may be useful for a wider
range of PMI-VSD locations, proximal disc delivery on232 The Journal of Thoracic and Cardiovascular Surgthe exterior of the RV is probably limited to more apical de-
fects. Further studies are necessary to evaluate the early and
long-term efficacy of this approach, and these results must
be compared with those of surgical and transcatheter
PMI-VSD closure.References
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